BEST Cord Blood Storage
The Blueprint for Tomorrow’s Health
A child’s birth presents a singular, time-critical window to isolate cellular assets that can never be replicated or recovered later. The rich biological material found in cord blood holds immense therapeutic potential, remaining preserved until required for critical clinical interventions. Meeting this pivotal moment head-on, CryoCord operates as an established institution deploying highly sophisticated laboratory systems to transform these raw biological materials into a secure, long-term medical repository for the family.
Cellular Fortresses
Raw biological materials require an uncompromising technical environment to retain their therapeutic value. CryoCord enforces absolute scientific integrity and regulatory compliance across its entire operational pipeline. Processing occurs in laboratories certified to current Good Manufacturing Practice (cGMP) by the National Pharmaceutical Regulatory Agency under the Ministry of Health Malaysia, adhering strictly to PIC/S standards. The core processing floor isolates cells within ten specialised Class 100 cleanrooms, verified by the National Environmental Balancing Bureau to completely mitigate contamination risks during open-system manipulation. As an AABB-accredited institution, the organisation also deploys a pioneering Biosafety Level 2 facility dedicated to genetic engineering products. This infrastructure actively supports clinical research, proprietary stem cell processing patents, and next-generation cell therapies. By removing environmental fluctuations from the equation, CryoCord laboratory guarantees that every isolated sample is meticulously evaluated under global quality assurance metrics to confirm exact cell counts, cell properties, and long-term viability.
The 20-Year Legacy
For over two decades, CryoCord has anchored Malaysia’s specialised healthcare sector, securing irreplaceable assets for more than 70,000 families. Anchored by a forward-looking clinical trajectory, this extensive track record ensures the organisation remains at the absolute cutting edge of cellular therapies, including active research into mesenchymal stem cells and CAR-T applications. Rather than leaving families to navigate complex science alone, CryoCord provides comprehensive customer support and clear, transparent educational resources to guide medical decision-making. This approach ensures that clinical-grade asset management at CryoCord remains integrated and accessible through every stage of the preservation lifecycle.
